Innovating Next Generation BBB-Penetrant AAVs for Gene Therapy
Time: 11:00 am
day: Conference Day One
Details:
- Discussing innovative advancements in IV administered AAV capsids to access the CNS
- Using engineered AAVs to treat neurodegenerative disorders and beyond
